Key Points
- Major shareholder William Gottwald sold 11,111 shares on Feb. 12 at an average price of $9.05 for about $100,555, reducing his stake by 1.85% to 588,253 shares, according to an SEC filing.
- Stock context: Tredegar has a market cap of ~$305.5M, trades near $8.75 (50‑day MA $8.09, 200‑day MA $7.84) with a 52‑week range of $6.25–$9.43, and carries an average analyst rating of “Sell” amid mixed research notes.
- High institutional ownership: Approximately 79.24% of Tredegar is owned by hedge funds and other institutional investors, with several funds recently increasing or initiating positions.
Tredegar Corporation (NYSE:TG - Get Free Report) major shareholder William Gottwald sold 11,111 shares of the company's stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $9.05, for a total value of $100,554.55. Following the sale, the insider owned 588,253 shares in the company, valued at approximately $5,323,689.65. This trade represents a 1.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.
Tredegar Stock Performance
Shares of Tredegar stock opened at $8.75 on Wednesday. The stock has a market cap of $305.51 million, a price-to-earnings ratio of -5.54 and a beta of 0.65. The stock has a 50 day moving average price of $8.09 and a 200-day moving average price of $7.84. Tredegar Corporation has a one year low of $6.25 and a one year high of $9.43.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the stock. Weiss Ratings restated a "sell (d-)" rating on shares of Tredegar in a report on Wednesday, January 21st. Wall Street Zen raised shares of Tredegar from a "hold" rating to a "strong-buy" rating in a research report on Saturday, November 15th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of "Sell".
Read Our Latest Analysis on TG
Institutional Trading of Tredegar
A number of large investors have recently made changes to their positions in the stock. Russell Investments Group Ltd. increased its stake in Tredegar by 531.0% in the 3rd quarter. Russell Investments Group Ltd. now owns 3,376 shares of the basic materials company's stock worth $27,000 after buying an additional 2,841 shares during the period. Torren Management LLC purchased a new stake in Tredegar in the 4th quarter valued at about $32,000. BNP Paribas Financial Markets grew its stake in Tredegar by 53.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 5,273 shares of the basic materials company's stock worth $42,000 after acquiring an additional 1,830 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in Tredegar by 225.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,889 shares of the basic materials company's stock worth $61,000 after acquiring an additional 4,771 shares in the last quarter. Finally, Heron Bay Capital Management purchased a new position in shares of Tredegar during the fourth quarter worth approximately $76,000. 79.24% of the stock is owned by hedge funds and other institutional investors.
Tredegar Company Profile
(
Get Free Report)
Tredegar Corporation is a diversified manufacturer specializing in high-performance plastic films and aluminum extrusions. Headquartered in Richmond, Virginia, the company operates through two primary segments—Films and Manufactured Products—serving a broad range of industries that include flexible packaging, medical devices, electronics, building and construction. Tredegar's operations focus on delivering tailored solutions that meet demanding specifications for barrier properties, film strength and extrusion tolerances.
The Films segment produces a variety of polyolefin films, including cast and blown polyethylene, BOPP (biaxially oriented polypropylene), barrier films and specialty medical-grade films.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
